novo nordisk zepbound - Search News

Order byBest matchMost fresh

News

Novo Nordisk, Lilly and Zepbound

· 3d · on MSN

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Continue reading

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy

1don MSN

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

3don MSN

Here’s how much extra weight is lost with Zepbound over Wegovy

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their ...

MarketBeat on MSN5h

Is It Time to Buy the Dip in Novo Nordisk Stock?

CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results